Clinical Trial Update: Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial results evaluating high-dose olanzapine for schizophrenia and schizoaffective disorder have been completed, according to the update. The study inv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Zyprexa (olanzapine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED